Endoscopy 2023; 55(S 02): S164
DOI: 10.1055/s-0043-1765419
Abstracts | ESGE Days 2023
ePoster

Red pill or blue pill? Effect of antithrombotic therapies on small bowel bleeding

L. Scaramella
1   Gastroenterology and Endoscopy Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
,
S. Chetcuti Zammit
2   Gastroenterology Department, Mater Dei Hospital, Msida, Malta
,
R. Sidhu
3   Academic Dept of Gastroenterology, Royal Hallamshire Hospital, Sheffield, United Kingdom
4   Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom
,
M. Vecchi
5   Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
1   Gastroenterology and Endoscopy Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
,
G. E. tontini
1   Gastroenterology and Endoscopy Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
5   Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
,
N. Nandi
5   Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
,
M. Topa
5   Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
1   Gastroenterology and Endoscopy Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
,
L. Elli
1   Gastroenterology and Endoscopy Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
› Institutsangaben
 

Aims Suspected SB bleeding (SBB) represents about 5-10% of all gastrointestinal bleeding and is the main indication for videocapsule endoscopy (VCE) [1] [2] [3]. We explored the impact of antithrombotic therapies on SBB with the use of VCE.

Methods Consecutive patients in two centres (Milan-Italy and Sheffield-UK) who underwent VCE from March 2001 to July 2020 were considered. Demographic and clinical parameters, drug therapy at the time of enteroscopy, procedure technical characteristics and adverse events were collected. VCE findings and diagnostic yield (DY) were evaluated.

Results 1756 VCEs (1497 patients) were collected, 1052 (957 patients) were performed for suspected SBB (20% overt, 80% occult) with a DY of 50.6% and no VCE retentions. 27 patients (27 VCEs) were on direct oral anticoagulants, 87 (88 VCEs) on other anticoagulants, and 115 (135 VCEs) on antiplatelet therapy. 198 patients (218 VCEs) were on monotherapy while 31 (32 VCEs) were on combined therapy. There were no differences in terms of completion rate, type of findings and DYs comparing each drug subgroup with others or with general SBB population, and monotherapy vs combined therapy (Table 1). Overt bleeding rate was similar in all the groups and general SBB population, even considering antithrombotic users vs patients not on therapy (23.2% vs 20.6%, p 0.59) or monotherapy vs combined therapy (17.9% vs 25%, p 0.34) ([Table 1]).

Zoom
Table 1 Technical aspects of enteroscopies performed for suspected SBB in patients receiving antithrombotic therapies.

Conclusions This study confirms VCE as a safe technique with high clinical impact in SB bleeding. Antithrombotic therapies do not appear to affect the DY or rate of overt bleeding and consequently can be considered safe in terms of risk of SBB.



Publikationsverlauf

Artikel online veröffentlicht:
14. April 2023

© 2023. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany